van der Zande Julia M J, Leone Anna E, Srinivas Shruthi, Wood Richard J, Benninga Marc A, Sanchez Raul E, Bali Puri Neetu, Vaz Karla, Yacob Desale, Di Lorenzo Carlo, Lu Peter L
Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.
Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
J Pediatr Gastroenterol Nutr. 2025 Jul;81(1):27-33. doi: 10.1002/jpn3.70057. Epub 2025 May 8.
Colonic manometry (CM) involves measurement of colonic neuromuscular activity and administration of a stimulant laxative, most commonly bisacodyl, which is part of the study protocol. Glycerin is another laxative used in the treatment of constipation. Our objective was to evaluate the effect of glycerin on colonic motility and compare the response to glycerin with each patient's response to bisacodyl.
We performed a retrospective review of all CM studies performed between May 2015 and May 2022. All studies with glycerin administration were included. Patient demographics, medical and surgical history, and results of each CM, including name, number, and dose of stimulant laxatives administered, colonic motor response after each stimulant, and final interpretation, were recorded.
We included 131 CM studies in 125 patients (53% female, median age at CM 10 years, interquartile range 7-14 years). Compared to bisacodyl, glycerin more commonly triggered fully propagated high-amplitude propagating contractions (HAPCs; 35% vs. 13%, p < 0.001) and led to a greater extent of propagation (propagation to sigmoid vs. to descending colon, p < 0.001). In 36% of studies, glycerin led to an improved response (stimulation of HAPCs when they were absent after bisacodyl, or HAPCs propagating through a greater extent of colon) compared to bisacodyl. In studies with an improved response, the median dose of glycerin in mL/kg was not significantly different compared to studies with the same/worse response.
Glycerin can trigger HAPCs in patients in whom bisacodyl was not able to do so. Incorporation of glycerin into standard CM protocols should be considered.
结肠测压(CM)包括测量结肠神经肌肉活动以及给予刺激性泻药,最常用的是比沙可啶,这是研究方案的一部分。甘油是另一种用于治疗便秘的泻药。我们的目的是评估甘油对结肠动力的影响,并将其与每位患者对比沙可啶的反应进行比较。
我们对2015年5月至2022年5月期间进行的所有CM研究进行了回顾性分析。纳入了所有给予甘油的研究。记录患者的人口统计学信息、内科和外科病史,以及每次CM的结果,包括所给予的刺激性泻药的名称、数量和剂量、每次刺激后结肠运动反应以及最终解读。
我们纳入了125例患者的131项CM研究(女性占53%,CM时的中位年龄为10岁,四分位间距为7 - 14岁)。与比沙可啶相比,甘油更常引发完全传播的高振幅传播性收缩(HAPCs;35%对13%,p < 0.001),并导致更大范围的传播(传播至乙状结肠与降结肠,p < 0.001)。在36%的研究中,与比沙可啶相比,甘油导致了更好的反应(在比沙可啶后无HAPCs时刺激产生HAPCs,或HAPCs在更大范围的结肠传播)。在反应改善的研究中,每毫升/千克甘油的中位剂量与反应相同/更差的研究相比无显著差异。
甘油能够在比沙可啶无法做到的患者中引发HAPCs。应考虑将甘油纳入标准CM方案中。